Order Article Reprints

Rizzo A, Miceli A, Racca M, Bauckneht M, Morbelli S, Albano D, Dondi F, Bertagna F, Galizia D, Muoio B, et al. Diagnostic Accuracy of [⁶⁸Ga]Ga Labeled Fibroblast-Activation Protein Inhibitors in Detecting Head and Neck Cancer Lesions Using Positron Emission Tomography: A Systematic Review and a Meta-Analysis. Pharmaceuticals. 2023; 16(12):1664. https://doi.org/10.3390/ph16121664

Rizzo, Alessio, Alberto Miceli, Manuela Racca, Matteo Bauckneht, Silvia Morbelli, Domenico Albano, Francesco Dondi, Francesco Bertagna, Danilo Galizia, Barbara Muoio, and et al. 2023. "Diagnostic Accuracy of [⁶⁸Ga]Ga Labeled Fibroblast-Activation Protein Inhibitors in Detecting Head and Neck Cancer Lesions Using Positron Emission Tomography: A Systematic Review and a Meta-Analysis" Pharmaceuticals 16, no. 12: 1664. https://doi.org/10.3390/ph16121664

Rizzo, A., Miceli, A., Racca, M., Bauckneht, M., Morbelli, S., Albano, D., Dondi, F., Bertagna, F., Galizia, D., Muoio, B., Annunziata, S., & Treglia, G. (2023). Diagnostic Accuracy of [⁶⁸Ga]Ga Labeled Fibroblast-Activation Protein Inhibitors in Detecting Head and Neck Cancer Lesions Using Positron Emission Tomography: A Systematic Review and a Meta-Analysis. Pharmaceuticals, 16(12), 1664. https://doi.org/10.3390/ph16121664